文献速递食管与纵隔外科

重症肌无力是机器人胸腺切除术后围手术期结局的不良预后因素

Myasthenia is a poor prognostic factor for perioperative outcomes after robotic thymectomy for thymoma.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

该回顾性研究分析了印度单中心7年内111例因胸腺瘤行机器人胸腺切除术的患者,其中68例合并重症肌无力、43例无重症肌无力。结果显示,肌无力组需切除周围结构及中转开胸的比例更高(P=0.02、P=0.04),术后并发症显著更多(P=0.02),但ICU停留、术后通气需求和住院时间无差异。肌无力患者更可能具有较高Masaoka分期(OR 1.96,95%CI 1.22-3.15)和侵袭性WHO组织学诊断(OR 1.58,95%CI 1.10-2.26)。中位随访4.2年共7例死亡(6.3%),因死亡数少,无法就肌无力对生存的影响得出结论(HR 0.51,95%CI 0.09-2.71;P=0.43)。

要点

  • 合并重症肌无力的胸腺瘤患者机器人胸腺切除术后并发症更多、中转开胸率更高。
  • 肌无力患者更可能具有较高Masaoka分期和侵袭性WHO组织学诊断。
  • 机器人手术未能克服肌无力相关的早期术后问题,生存影响尚不明确。

核心结论

  • 胸腺瘤合并重症肌无力与更多邻近结构切除、更高术后并发症和中转开胸相关。
  • 机器人胸腺瘤切除未能克服肌无力相关的早期术后问题。

研究设计与样本

  • 回顾性分析印度单中心7年前瞻性维护的111例因胸腺瘤行机器人胸腺切除术的患者数据。

主要发现

  • 肌无力组68例,非肌无力组43例;肌无力组需切除周围结构及中转开胸比例更高(P=0.02、P=0.04)。
  • 肌无力组术后并发症显著更高(P=0.02),但ICU停留、术后通气需求和住院时间无差异。
  • 肌无力患者更可能具有较高Masaoka分期(OR 1.96,95%CI 1.22-3.15)和侵袭性WHO组织学诊断(OR 1.58,95%CI 1.10-2.26)。
  • 中位随访4.2年共7例死亡(6.3%),肌无力组5例、非肌无力组2例;生存分析因死亡数少证据不足(HR 0.51,95%CI 0.09-2.71;P=0.43)。

临床怎么用

  • 对胸腺瘤合并重症肌无力患者行机器人胸腺切除术前,应充分评估围手术期风险并告知并发症和中转开胸可能性更高。

局限性

  • 回顾性单中心研究,样本量有限。
  • 死亡事件数少,无法就肌无力对生存的影响得出结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of this study was to compare the early and intermediate surgical outcomes, including the survival of those with and without myasthenic thymoma, following robotic thymectomy. METHODS: This is a retrospective analysis of prospectively maintained data of 111 patients who underwent robotic thymectomy for thymoma over 7 years in a thoracic surgery centre in India. We performed a comparative analysis of demographics, intraoperative variables and postoperative outcomes including survival of those with and without myasthenic thymoma. RESULTS: Of 111 patients, 68 patients were myasthenic and 43 were non-myasthenic. The need to resect surrounding structures and conversions was greater in the myasthenic group (P = 0.02, P = 0.04). Postoperative complications were significantly higher in the myasthenic group (P = 0.02). No differences were observed in intensive care unit stay, the need for postoperative ventilation and the hospital stay. On correlation, a higher Masaoka stage [odds ratio 1.96, 95% confidence interval (CI) 1.22-3.15] and an aggressive World Health Organization histological diagnosis (odds ratio 1.58, 95% CI 1.10-2.26) were more likely in patients with myasthenia gravis. A total of 7 deaths (6.3%) occurred during the median follow-up of 4.2 years, 5 among those with myasthenic thymoma and 2 among patients with non-myasthenic thymoma. Due to the small number of deaths, there is insufficient evidence to draw any conclusion about the effect of myasthenia gravis on survival after surgery (hazard ratio 0.51, 95% CI 0.09-2.71; P = 0.43). CONCLUSIONS: The presence of myasthenia with thymoma is associated with more adjacent structure resection, higher postoperative complications and more conversions. The use of robotic surgery for thymoma resection in patients with myasthenia could not overcome the early postoperative problems related to myasthenia gravis.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kumar A, Asaf BB, Pulle MV, et al. Myasthenia is a poor prognostic factor for perioperative outcomes after robotic thymectomy for thymoma. Eur J Cardiothorac Surg. 2021. PMID: 33279991. doi:10.1093/ejcts/ezaa406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。